Human Lupus Plasma Pro-Atherogenic Effects on Cultured Macrophages Are Not Mitigated by Statin Therapy: A Mechanistic LAPS Substudy

Background and Objectives: Atherosclerotic cardiovascular disease (CVD) remains a major cause of morbidity and mortality in persons with systemic lupus erythematosus (SLE, lupus). Atherosclerosis, which involves interplay between cholesterol metabolism and cellular inflammatory pathways, is primaril...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Medicina (Kaunas)
Egile Nagusiak: Reiss, Allison B., Arain, Hirra A., Kasselman, Lora J., Renna, Heather A., Zhen, Juan, Voloshyna, Iryna, DeLeon, Joshua, Carsons, Steven E., Petri, Michelle
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI 2019
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6780986/
https://ncbi.nlm.nih.gov/pubmed/31438615
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/medicina55090514
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak